Movement Alert｜Colgate-Palmolive Intraday Rise 3.07% in Regular Trading, UBS Says Q3 Results Should Be Broadly In Line

Market Focus10-22

On October 22, Colgate-Palmolive rose 3.07% in Regular Trading, trading at $96.3 per share, with turnover of $67.75 million.

The most recent company-specific catalyst was a research note indicating Colgate-Palmolive is expected to post third-quarter results on October 30 that are broadly in line with Street estimates, while management is also seen reiterating its outlook.

The note said investor focus is shifting toward 2027 as inflation pressure and foreign-exchange headwinds are weighed against topline momentum. UBS added that higher input costs make the lower end of the company’s EPS growth range more likely, but it still expects guidance to be maintained rather than meaningfully changed. Earlier this month, UBS lowered its price target to $106 from $109 while keeping a Buy rating, and other firms also updated targets, with JPMorgan at $104 and BofA at $100.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment